Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters California Cannabis Market with Dispensary in Southern Desert

Cannabis industry investment builder Nabis Holdings has purchased Desert Hot Springs’ Desert’s Finest dispensary The new asset gives Nabis an entry point into the world’s largest cannabis industry market, and it is strategically located near the annual Coachella Music Festival Nabis envisions revenues of C$14.8 million this year with a leap to C$167.9 million next […]

Pressure BioSciences Inc.’s (PBIO) Entry into CBD Market Aims Next-Gen Nanoemulsification Platform at Critical Water-Solubility Issues

PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized bioavailability CBD sales are projected to reach $89 billion by 2024 with a CAGR of 37 percent (2018-2024 forecast period) Analysts predict that the biggest short-term challenge for CBD businesses will be oversaturation […]

City View Green Holdings Inc. (CSE: CVGR) Strengthening Finance Strategy, Constructing Cannabis Production Facility Near Toronto

City View Green Holdings is completing the construction of a 40,000-square-foot cannabis cultivation facility in the Toronto-area following an all-clear notice from Health Canada under its new licensing regulations City View began trading on the Canadian Stock Exchange in March and has recently cleared more than half a million dollars in debt as part of […]

SinglePoint Inc. (SING) Sees Growth Across Multiple Revenue Streams

Direct Solar achieved more than $3 million in solar contracts in just 60 days SING has expanded into the commercial solar market, opening up additional revenue streams CEO shared news from multiple revenue streams on MoneyTV with Donald Baillargeon SinglePoint Inc. (OTCQB: SING) is a well-diversified holding company. What started as a full-service, mobile-technology provider […]

Research Highlights Virtues of INmune Bio Inc.’s (NASDAQ: INMB) Strategy in Fighting Cancer with Body’s Own Natural Cells

California-based INmune Bio is developing therapies to battle cancers and Alzheimer’s disease by more effectively engaging the body’s own natural defenses Research published in a peer-reviewed scientific journal shows a mechanism by which scientists can track and strategize natural killer cell promotion as an innate physical response to cancer in lieu of other pharmaceutical inducements […]

Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Plans to Acquire Truverra Inc.

Supreme’s Truverra acquisition is valued at approximately C$20 million Supreme Cannabis intends to repurpose Truverra’s Health Canada-licensed facility to produce cannabis extracts for use in concentrates and vaping liquids The company will gain entry into Europe through Truverra’s subsidiary The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) intends to acquire privately held, […]

Golden Developing Solutions Inc. (DVLP) Announces Record Preliminary Revenues for Q2 2019

Record sales attributed to DVLP’s operational entity and subsidiaries CEO says that DVLP has built a diverse ecosystem of products and services and is creating a community of consumers and businesses in the cannabis space The company’s new 25,000-square-foot facility is expected to “exponentially amplify” its manufacturing capabilities Golden Developing Solutions Inc. (OTC: DVLP) reported […]

 

From Our Blog

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

March 31, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Rotate your device 90° to view site.